middle.news
LTR Pharma Completes Phase II Recruitment for SPONTAN, Data Due Q2 2026
8:42am on Thursday 5th of March, 2026 AEDT
•
Healthcare
Read Story
LTR Pharma Completes Phase II Recruitment for SPONTAN, Data Due Q2 2026
8:42am on Thursday 5th of March, 2026 AEDT
Key Points
Phase II recruitment completed with 27 participants across three cohorts
Dedicated cohort of participants aged 65 and older included
Study follows FDA Pre-IND guidance and supports 505(b)(2) regulatory pathway
Dosing underway with single and multiple doses over a 15-day residential period
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
LTR PHARMA (ASX:LTP)
OPEN ARTICLE